These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 27191497

  • 21. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
    Han N, Li H, Wang H.
    Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
    [Abstract] [Full Text] [Related]

  • 23. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX, Liu YH, Xiang JW, Wu QN, Xu LB, Luo XL, Zhu XL, Liu C, Xu FP, Luo DL, Mei P, Xu J, Zhang KP, Chen J.
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [Abstract] [Full Text] [Related]

  • 24. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
    Tang FY, Pai MH, Chiang EP.
    J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.
    Ma L, Shao Z, Zhao Y.
    Pathol Res Pract; 2019 Jun; 215(6):152382. PubMed ID: 30890278
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
    Nie ZC, Weng WH, Shang YS, Long Y, Li J, Xu YT, Li Z.
    Int J Clin Exp Pathol; 2015 Jun; 8(5):4745-54. PubMed ID: 26191164
    [Abstract] [Full Text] [Related]

  • 27. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X, Shi H, Tang H, Fang Z, Wang J, Cui S.
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [Abstract] [Full Text] [Related]

  • 28. miR-451 suppresses EMT and metastasis in glioma cells.
    Nan Y, Guo L, Lu Y, Guo G, Hong R, Zhao L, Wang L, Ren B, Yu K, Zhong Y, Huang Q.
    Cell Cycle; 2021 Jul; 20(13):1270-1278. PubMed ID: 34048322
    [Abstract] [Full Text] [Related]

  • 29. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

  • 30. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y, Qian W, Zhang Y, Peng W, Li J, Gu Q, Ji D, Zhang Z, Wang Q, Zhang D, Sun Y.
    BMC Cancer; 2019 Jun 13; 19(1):576. PubMed ID: 31196027
    [Abstract] [Full Text] [Related]

  • 31. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Pan Q, Meng L, Ye J, Wei X, Shang Y, Tian Y, He Y, Peng Z, Chen L, Chen W, Bian X, Wang R.
    Cancer Lett; 2017 Apr 28; 392():26-38. PubMed ID: 28163188
    [Abstract] [Full Text] [Related]

  • 32. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL, Wang J, Zhang CY, Shen YQ, Wang HM, Ding L, Gu YC, Lou JT, Zhao XT, Ma ZL, Jin YX.
    Oncotarget; 2016 Sep 13; 7(37):59287-59298. PubMed ID: 27494902
    [Abstract] [Full Text] [Related]

  • 33. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
    Wang F, Ruan XJ, Zhang HY.
    Tumori; 2015 Sep 13; 101(2):238-45. PubMed ID: 25908029
    [Abstract] [Full Text] [Related]

  • 34. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY, Jiao DM, Wang J, Hu H, Tang X, Chen J, Mou H, Lu W.
    Oncotarget; 2016 Apr 26; 7(17):24510-26. PubMed ID: 27014910
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M, Yu W, Gao J, Ma W, Frentsch M, Thiel A, Liu M, Rahman N, Qin Z, Li X.
    J Cell Physiol; 2020 Feb 26; 235(2):1588-1600. PubMed ID: 31309555
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.
    Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, Gao X, Wang X.
    Tumour Biol; 2015 Mar 26; 36(3):1701-10. PubMed ID: 25371073
    [Abstract] [Full Text] [Related]

  • 37. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J, Yuan L.
    Biomed Pharmacother; 2018 Oct 26; 106():109-116. PubMed ID: 29957460
    [Abstract] [Full Text] [Related]

  • 38. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, Richler C, Fellig Y, Sorin V, Hubert A, Hochberg A, Czerniak A.
    Biochim Biophys Acta; 2014 Jul 26; 1843(7):1414-26. PubMed ID: 24703882
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L, Li X, Zhang X, Lv Z, He G, Zhao W, Ren X, Li Y, Bian X, Liao W, Liu W, Yang G, Ding Y.
    Gastroenterology; 2013 Mar 26; 144(3):624-635.e4. PubMed ID: 23201162
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
    Han K, Chen X, Bian N, Ma B, Yang T, Cai C, Fan Q, Zhou Y, Zhao TB.
    Oncotarget; 2015 Apr 20; 6(11):8875-89. PubMed ID: 25823925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.